Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease
about
The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewDonor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice.Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host DiseaseDonor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease.CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.Context and location dependence of adaptive Foxp3(+) regulatory T cell formation during immunopathological conditionsAlternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis.Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability.Generation and function of induced regulatory T cells.CD8(+) Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4(+) Tregs in miceDistinctive Leukocyte Subpopulations According to Organ Type in Cynomolgus MacaquesInhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.Regulatory T-Cell Therapy for Graft-versus-host Disease.Therapeutic potential of induced and natural FoxP3(+) regulatory T cells for the treatment of Graft-versus-host disease.The role of regulatory T cells in the biology of graft versus host disease.Interleukin-2 and STAT5 in regulatory T cell development and functionT regulatory cells in childhood arthritis--novel insights.Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning.Regulatory T cells in immune-mediated renal disease.T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD.Notch Ligand Delta-like 4 Promotes Regulatory T Cell Identity in Pulmonary Viral Infection.Mutual antagonism of TGF-beta and Interleukin-2 in cell survival and lineage commitment of induced regulatory T cells.Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.γδ T cells restrain extrathymic development of Foxp3+-inducible regulatory T cells via IFN-γ.Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases.Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic GVHD: a pilot study.Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis.Kaempferol Promotes Transplant Tolerance by Sustaining CD4+FoxP3+ Regulatory T Cells in the Presence of Calcineurin Inhibitor.
P2860
Q28066083-8E823457-7FB5-40C2-9A23-B6B7C843A303Q34293038-602C373C-0D8D-4EE9-A7E8-B232A06E6688Q35252405-DB054E1D-3AB3-425A-9EF9-102966912D93Q35553553-0784B0AC-C7DC-4F7D-BBAF-557E00A02F90Q35815893-9AACAB2C-F764-40C9-B70B-8FC0B08AAF26Q35865094-1EEDFD91-B247-45F6-B270-5AA7D2DCB7EEQ36055096-FB6A7C49-BDDE-4624-AF36-2351822A7FFFQ36457068-63D8EABC-2547-45F0-ABA7-054B3F680D93Q36853641-484CC862-465B-4B99-AB1F-CE91969DA1D0Q36890286-FDF12C0F-9D2C-4812-A9B0-132B7A64802DQ36938160-F9029935-700A-499C-9627-AC6ACFCC7C45Q37079114-FB5148DF-79E7-40C2-9365-BA9C35D7D84BQ37171759-5024F3FB-5AA0-4233-9261-2DF50991895FQ37186477-C702974A-46F3-4EFE-9E40-153A3201C12EQ37309438-70EEF921-F698-433B-A380-6754EB700513Q38000048-74CC5FB0-E34B-4A8F-BE95-642D8B9E502FQ38117369-B3FCC47A-7DD3-4C26-8A8B-5DD5893F9E84Q38140904-C5621AF5-7E7A-4841-8024-82A933593A83Q38167815-D4CCD581-27E7-48F4-9F68-C31B074DB248Q38193165-C71E24A6-F9EC-4BAF-83D5-375B0B55AFC7Q38553166-A3C4CDC3-6AC4-43C7-A819-9C1E3DD57728Q39017604-815ADF31-FABE-4525-AAE7-06F66E971042Q40183485-7E80FF17-A611-4196-83DE-7395372A2108Q40375954-C0B1992A-3D07-462B-8337-56A3582945CEQ41825885-D1F4D061-71C9-4D60-A622-1AAEB8B369F7Q42381249-2CD5DA35-4EEF-4D4A-A49F-15BFF057E234Q42831154-32A23134-C8D8-4D6F-BBE0-D3FF6A19C1E9Q48155143-E84642F6-86B8-49AC-BBB0-0A9E1512BAF9Q49350557-068625AF-ACCC-427E-9D7C-93B2E6A04181Q51528344-1768B92C-7E1C-4076-8824-3FFAF6A7FC60Q53570409-CD605562-420B-4FD1-8160-DD6AC384532B
P2860
Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Instability of Foxp3 expressio ...... gate graft versus host disease
@ast
Instability of Foxp3 expressio ...... gate graft versus host disease
@en
type
label
Instability of Foxp3 expressio ...... gate graft versus host disease
@ast
Instability of Foxp3 expressio ...... gate graft versus host disease
@en
prefLabel
Instability of Foxp3 expressio ...... gate graft versus host disease
@ast
Instability of Foxp3 expressio ...... gate graft versus host disease
@en
P2093
P2860
P1476
Instability of Foxp3 expressio ...... gate graft versus host disease
@en
P2093
Masahiko Mihara
Richard Komorowski
William R Drobyski
P2860
P304
P356
10.1158/1078-0432.CCR-10-3347
P407
P50
P577
2011-05-10T00:00:00Z